Christine A Pellizzari Insmed Inc (INSM) insider trading activity

Christine A Pellizzari is Chief Legal Officer of INSMED Inc. Currently has a direct ownership of 149,985 shares of INSM, which is worth approximately $11 Million. The most recent transaction as insider was on May 15, 2021, when has been sold 2,546 shares (Common Stock) at a price of $26.23 per share, resulting in proceeds of $66,782. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K

0% 3M change

0% 12M change

Total Value Held $11 Million

Christine A Pellizzari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2021	SELL Payment of exercise price or tax liability	$66,782 $26.23 p/Share	2,546 Reduced 1.67%	149,985 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	11,810 Added 7.19%	152,531 Common Stock
Feb 09 2021	SELL Open market or private sale	$681,750 $45.0 p/Share	15,150 Reduced 9.72%	140,721 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$164,378 $10.85 p/Share	15,150 Added 8.86%	155,871 Common Stock
Feb 08 2021	SELL Open market or private sale	$281,280 $43.95 p/Share	6,400 Reduced 4.35%	140,721 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$69,440 $10.85 p/Share	6,400 Added 4.17%	147,121 Common Stock
Jan 26 2021	SELL Open market or private sale	$114,504 $44.04 p/Share	2,600 Reduced 1.81%	140,721 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$28,210 $10.85 p/Share	2,600 Added 1.78%	143,321 Common Stock
Jan 25 2021	SELL Open market or private sale	$911,400 $43.4 p/Share	21,000 Reduced 12.99%	140,721 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$227,850 $10.85 p/Share	21,000 Added 12.52%	146,721 Common Stock
Jan 21 2021	SELL Open market or private sale	$830,200 $41.51 p/Share	20,000 Reduced 12.44%	140,721 Common Stock
Jan 21 2021	BUY Exercise of conversion of derivative security	$217,000 $10.85 p/Share	20,000 Added 11.72%	150,721 Common Stock
Jan 20 2021	SELL Open market or private sale	$398,700 $39.87 p/Share	10,000 Reduced 6.63%	140,721 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$108,500 $10.85 p/Share	10,000 Added 6.22%	150,721 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	9,183 Added 6.13%	140,721 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$21,723 $33.42 p/Share	650 Reduced 0.49%	131,538 Common Stock
Jan 03 2021	SELL Payment of exercise price or tax liability	$60,388 $33.29 p/Share	1,814 Reduced 1.35%	132,188 Common Stock
Nov 05 2020	BUY Exercise of conversion of derivative security	$627,326 $15.82 p/Share	39,654 Added 22.83%	134,002 Common Stock
Nov 04 2020	SELL Open market or private sale	$1,030,200 $34.34 p/Share	30,000 Reduced 24.13%	94,348 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$377,400 $12.58 p/Share	30,000 Added 21.43%	110,013 Common Stock
Nov 03 2020	SELL Open market or private sale	$3,699,508 $32.51 p/Share	113,796 Reduced 54.67%	94,348 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$1,267,687 $11.14 p/Share	113,796 Added 46.16%	132,744 Common Stock
May 15 2020	SELL Payment of exercise price or tax liability	$40,099 $25.46 p/Share	1,575 Reduced 1.64%	94,348 Common Stock

Also insider at

CLSN

Celsion CORP Healthcare

Director

TPST

Tempest Therapeutics, Inc. Healthcare

SNCE

Science 37 Holdings, Inc. Healthcare

Chief Legal and HR Officer

CAP